Merck & Co Inc (MRK)
121.44
-0.08
(-0.07%)
USD |
NYSE |
Mar 18, 16:00
121.99
+0.55
(+0.45%)
After-Hours: 20:00
Merck Market Cap: 307.59B for March 18, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 15, 2024 | 307.77B |
March 14, 2024 | 305.21B |
March 13, 2024 | 309.39B |
March 12, 2024 | 310.65B |
March 11, 2024 | 310.93B |
March 08, 2024 | 312.78B |
March 07, 2024 | 314.02B |
March 06, 2024 | 313.41B |
March 05, 2024 | 311.08B |
March 04, 2024 | 314.17B |
March 01, 2024 | 321.54B |
February 29, 2024 | 322.03B |
February 28, 2024 | 324.66B |
February 27, 2024 | 326.79B |
February 26, 2024 | 326.31B |
February 23, 2024 | 327.85B |
February 22, 2024 | 327.37B |
February 21, 2024 | 324.48B |
February 20, 2024 | 322.58B |
February 16, 2024 | 323.65B |
February 15, 2024 | 320.48B |
February 14, 2024 | 318.66B |
February 13, 2024 | 317.67B |
February 12, 2024 | 317.44B |
February 09, 2024 | 317.72B |
Date | Value |
---|---|
February 08, 2024 | 320.66B |
February 07, 2024 | 322.84B |
February 06, 2024 | 321.34B |
February 05, 2024 | 319.57B |
February 02, 2024 | 320.15B |
February 01, 2024 | 320.08B |
January 31, 2024 | 305.89B |
January 30, 2024 | 308.00B |
January 29, 2024 | 307.04B |
January 26, 2024 | 305.87B |
January 25, 2024 | 304.13B |
January 24, 2024 | 300.96B |
January 23, 2024 | 303.39B |
January 22, 2024 | 302.35B |
January 19, 2024 | 300.99B |
January 18, 2024 | 300.10B |
January 17, 2024 | 299.06B |
January 16, 2024 | 299.97B |
January 12, 2024 | 300.33B |
January 11, 2024 | 299.82B |
January 10, 2024 | 300.91B |
January 09, 2024 | 299.82B |
January 08, 2024 | 297.16B |
January 05, 2024 | 296.76B |
January 04, 2024 | 296.23B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
160.34B
Minimum
Mar 23 2020
327.85B
Maximum
Feb 23 2024
223.00B
Average
205.99B
Median
Oct 14 2019
Market Cap Benchmarks
Amgen Inc | 145.17B |
Gilead Sciences Inc | 91.27B |
Johnson & Johnson | 377.62B |
Harpoon Therapeutics Inc (DELISTED) | 492.35M |
Moderna Inc | 39.84B |
Market Cap Related Metrics
PE Ratio | 867.50 |
PS Ratio | 5.140 |
Price to Book Value | 8.185 |
Price to Free Cash Flow | 33.80 |
Price | 121.44 |
Earnings Yield | 0.12% |
Operating PE Ratio | 104.64 |
Normalized PE Ratio | 380.89 |